Non-small cell lung cancer (nsclc) Trials in Detroit, United States
Conditions / Non-small cell lung cancer (nsclc) / Detroit, United States
Non-small cell lung cancer (nsclc) has been the subject of sustained clinical investigation across multiple research sites.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06162221 | Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC | RECRUITING | PHASE1/PHASE2 |
| NCT06074588 | Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) | RECRUITING | PHASE3 |
| NCT02771626 | Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) | TERMINATED | PHASE1/PHASE2 |
| NCT03260491 | U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT05176483 | Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors | RECRUITING | PHASE1 |
| NCT07291037 | Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations | RECRUITING | PHASE3 |
| NCT06128551 | Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT06026410 | KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors | RECRUITING | — |
| NCT05891171 | Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT01712217 | A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib | COMPLETED | PHASE1/PHASE2 |